课题基金 / 基金详情

Atlanta Clinical and Translational Science Institute (UL1)

Atlanta Clinical and Translational Science Institute (UL1)
亚特兰大临床与转化科学研究所 (UL1)
批准号:
7900242
负责人:
DAVID S STEPHENS
金额:
$99.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-05 至 2012-09-04

项目摘要

项目成果

DAVID S STEPHENS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In response to the national effort to develop, improve, and deliver clinical and translational science, the leadership of Emory University challenged both faculty and the administration to transform clinical and translational research within the University and its numerous components and affiliates. With ongoing collaborations in heath-care, education, and interdisciplinary research, Emory also chose to engage two of its close academic partners in metropolitan Atlanta - Morehouse School of Medicine (MSM) and Georgia Institute of Technology (GA Tech) to form the Atlanta Clinical and Translational Science Institute (Atlanta-CTSI). This strategic multi-institutional alliance offered compelling and unique advantages. Emory is one of the nation's leading healthcare and academic research institutions, ranking 19th nationally in NIH funded research; GA Tech is a national leader in biomedical engineering and the application of innovative systems engineering to health care solutions; and MSM is a historically black medical school recognized as a national leader in expanding the ethnic diversity of biomedical research, dedicated to community engagement in efforts to eliminate health disparities and serving as a pipeline for training minority investigators. The established partnerships and diverse faculty enable the Atlanta-CTSI to combine strong clinical, translational,training and basic discovery programs at Emory with the health disparities, training and community outreach focus of MSM together with the engineering and bioinformatics achievements of GA Tech. The planning efforts also led to the creation of a new and innovative pediatric clinical and translational research program and a partnership with Children's Healthcare of Atlanta, new partnerships with the emerging Georgia biotechnology community and with Kaiser Permanente, and the further development of partnerships with state sponsored agencies (Georgia Research Alliance) and with the Department of Veterans Affairs. The Atlanta-CTSI is a model designed to harness the scientific, technological, and clinical advantages of these institutions around the major aims of discovery, training, and community engagement to create a new city wide home for clinical and translational research. Other new programs resulting from the synergistic partnership include an innovative pilot projects program PiCo-TraCS, integrated clinical interactions and biomedical informatics networks (CIN and BIN), creation of a technology "pipeline" andAcademy for Translational Methods Development, a bioinformatics Leapfrog initiative, a facilitating Office of Human Studies Research, creative K30/K12 and T32 programs, and an outstanding community engagement program. The institutional support for the Atlanta-CTSI is exceptional. The Atlanta- CTSI utilizes the complementary strengths of Emory, MSM, and GA Tech and other GA institutions to promote the discipline of clinical and translational science and to improve the healthcare of our community.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DISSEMINATION OF MACROLIDE RESISTANCE ELEMENTS IN STREPTOCOCCUS PNEUMONIAE
  • 批准号:
    9888324
  • 项目类别:
  • 资助金额:
    $16.41万
  • 财政年份:
    2019
  • 负责人:
    DAVID S STEPHENS
  • 依托单位:
DISSEMINATION OF MACROLIDE RESISTANCE ELEMENTS IN STREPTOCOCCUS PNEUMONIAE
  • 批准号:
    10027021
  • 项目类别:
  • 资助金额:
    $15.74万
  • 财政年份:
    2019
  • 负责人:
    DAVID S STEPHENS
  • 依托单位:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
  • 批准号:
    8366095
  • 项目类别:
  • 资助金额:
    $29.36万
  • 财政年份:
    2011
  • 负责人:
    DAVID S STEPHENS
  • 依托单位:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
  • 批准号:
    8366091
  • 项目类别:
  • 资助金额:
    $29.36万
  • 财政年份:
    2011
  • 负责人:
    DAVID S STEPHENS
  • 依托单位:
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data